1-4 of 4
Benno Rattel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule

Elizabeth Pham, Matthias Friedrich, Famke Aeffner, Michael Lutteropp, Natalie F. Mariano, Petra Deegen, Christoph Dahlhoff, Franziska Vogel, Claudia Bluemel, John M. Harrold, Christian Brandl, Natalia Grinberg, Benno Rattel, Angela Coxon, Julie M. Bailis
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (10): 1977–1987.
https://doi.org/10.1158/1535-7163.MCT-21-0236
Published: 01 October 2021
View article titled, Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule
Open the PDF for Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule in another window
Includes: Supplementary data
Journal Articles

Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII

Alexander Sternjak, Fei Lee, Oliver Thomas, Mercedesz Balazs, Joachim Wahl, Grit Lorenczewski, Ines Ullrich, Markus Muenz, Benno Rattel, Julie M. Bailis, Matthias Friedrich
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (5): 925–933.
https://doi.org/10.1158/1535-7163.MCT-20-0508
Published: 01 May 2021
View article titled, Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII
Open the PDF for Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII in another window
Includes: Supplementary data
Journal Articles

Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia

Matthias Friedrich, Anja Henn, Tobias Raum, Monika Bajtus, Katja Matthes, Larissa Hendrich, Joachim Wahl, Patrick Hoffmann, Roman Kischel, Majk Kvesic, Jerry W. Slootstra, Patrick A. Baeuerle, Peter Kufer, Benno Rattel
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2014) 13 (6): 1549–1557.
https://doi.org/10.1158/1535-7163.MCT-13-0956
Published: 04 June 2014
View article titled, Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
Open the PDF for Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia in another window
Includes: Supplementary data
Journal Articles

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, Markus Voelkel, Petra Deegen, Doris Rau, Roman Kischel, Patrick Hoffmann, Christian Brandl, Joachim Schuhmacher, Peter Mueller, Ricarda Finnern, Melanie Fuergut, Dieter Zopf, Jerry W. Slootstra, Patrick A. Baeuerle, Benno Rattel, Peter Kufer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (12): 2664–2673.
https://doi.org/10.1158/1535-7163.MCT-12-0042
Published: 09 December 2012
View article titled, Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens
Open the PDF for Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens in another window